# Vor Biopharma Inc.: Form SCHEDULE 13D, filed Dec 23, 2025

- Company: [Vor Biopharma Inc.](/companies/vor.md) (CIK 1817229)
- Form: SCHEDULE 13D
- Filed: 2025-12-23
- Accepted by EDGAR: Dec 23, 2025, 16:05 ET
- Period: not reported
- Accession: 0001193125-25-330843
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817229/000119312525330843/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817229/000119312525330843/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817229/000119312525330843/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Dec 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-330843. Last ingested by Listed: Nov 5, 2026, 14:02 ET. No prices; not investment advice.